Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-02

Clinical Trial Update: Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma [EARLY_Phase 1]

View source ↗

Summary

Early-phase study evaluating the use of 18F-FDOPA PET imaging to plan surgery and radiation therapy for adults with newly diagnosed malignant gliomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 18F-FDOPA (fluorodopa (18F))

Snippet

Sponsor: Mayo Clinic | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | EARLY_Phase 1 | Status: COMPLETED